ResearcherLanzhou University Second HospitalActive in the last 2 years

Minxue Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4562-0038; OpenAlex author ID A5011043365. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

Identification and validation of prognostic biomarkers related to tumor immune invasion in pancreatic cancer. Co-author DOI 10.3389/fgene.2025.1556544 ↗
Anillin is a prognostic factor and is correlated with genovariation in pancreatic cancer based on databases analysis. Co-author DOI 10.3892/ol.2020.12368 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Xinyuan Zhou · 1 shared paper, 2025 · strength 0.33
- Paper Identification and validation of prognostic biomarkers related to tumor immune invasion in pancreatic cancer. DOI 10.3389/fgene.2025.1556544 ↗
Chen Wang · 1 shared paper, 2025 · strength 0.33
- Paper Identification and validation of prognostic biomarkers related to tumor immune invasion in pancreatic cancer. DOI 10.3389/fgene.2025.1556544 ↗
Chen Wang · 1 shared paper, 2021 · strength 0.14
- Paper Anillin is a prognostic factor and is correlated with genovariation in pancreatic cancer based on databases analysis. DOI 10.3892/ol.2020.12368 ↗
Yuanhua Nie · 1 shared paper, 2021 · strength 0.14
- Paper Anillin is a prognostic factor and is correlated with genovariation in pancreatic cancer based on databases analysis. DOI 10.3892/ol.2020.12368 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.